NAUT - Nautilus Biotechnology, Inc.
3.48
-0.300 -8.621%
Share volume: 432,043
Last Updated: 03-27-2026
Measuring And Control Equipment/Lab Analytical Instruments:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$3.78
-0.30
-0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 04-30-2024 | 07-30-2024 | 10-29-2024 | 02-27-2025 | 04-29-2025 | 07-31-2025 | |
| Assets | |||||||
| Total Assets | 288.650 M | 272.747 M | 259.704 M | 242.743 M | 227.690 M | 213.189 M | |
| Current Assets | 185.094 M | 170.933 M | 144.205 M | 132.826 M | 141.601 M | 150.725 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 155.637 M | 142.558 M | 136.200 M | 102.247 M | 105.572 M | 113.416 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 25.729 M | 24.885 M | 4.409 M | 27.646 M | 33.238 M | 34.457 M | |
| Total Non-current Assets | 66.292 M | 65.466 M | 80.618 M | 76.405 M | 54.023 M | 31.636 M | |
| Property Plant Equipment | 4.525 M | 4.694 M | 4.324 M | 4.076 M | 3.790 M | 3.728 M | |
| Other Assets | 99.031 M | 97.120 M | 111.175 M | 105.841 M | 82.299 M | 58.736 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 288.650 M | 272.747 M | 259.704 M | 242.743 M | 227.690 M | 213.189 M | |
| Total liabilities | 39.158 M | 37.468 M | 36.270 M | 34.013 M | 33.255 M | 32.095 M | |
| Total current liabilities | 9.212 M | 8.681 M | 8.662 M | 7.632 M | 8.156 M | 8.137 M | |
| Accounts Payable | 1.860 M | 1.627 M | 1.487 M | 987.000 K | 841.000 K | 974.000 K | |
| Other liabilities | 29.946 M | 28.787 M | 27.608 M | 26.381 M | 25.099 M | 23.958 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 29.946 M | 28.787 M | 27.608 M | 26.381 M | 25.099 M | 23.958 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 249.492 M | 235.279 M | 223.434 M | 208.730 M | 194.435 M | 181.094 M | |
| Common stock | 471.206 M | 474.804 M | 478.128 M | 481.692 M | 483.878 M | 485.682 M | |
| Retained earnings | -220.969 M | -238.979 M | -255.425 M | -273.019 M | -289.632 M | -304.665 M |